Pelthos Therapeutics Inc.
PTHSHealthcare|Biotechnology|US
$9.36
+0.06 (+0.65%)
DCF Value
$113.99
Cash / Share
$6.94
About
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
Stock Price
-75.0%(1Y)
1M
-54.3%
3M
-67.0%
6M
-63.3%
YTD
-69.8%
1Y
-72.5%
3Y
-20.7%
5Y
-20.7%
Pipeline Summary
0 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Key Facts
Market Cap$35.8M
Employees92 (+2200% YoY)
CEOScott Plesha
IPO DateFeb 16, 2024
Beta3.11
52-Week Range$9.02 – $37.4
Avg Volume60,041
ExchangeAMEX
Websitepelthos.com
Ownership
Float30.7%
Shares Outstanding3.8M
Recent Insider Trades
Greenleaf PeterSELL
Oct 2, 2026797 shares @ $21.17
Friedberg Ezra MSELL
Oct 2, 2026558 shares @ $20.72
Pauls MatthewSELL
Oct 2, 2026786 shares @ $21.00
Friedberg Ezra MSELL
Jul 2, 2026534 shares @ $26.03
Friedberg Ezra MSELL
Jul 2, 202624 shares @ $27.33
Peers
Recent News
Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026
Nov 4, 2026 · globenewswire.com
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
Oct 30, 2026 · globenewswire.com
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
Oct 27, 2026 · globenewswire.com
Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
Oct 6, 2026 · globenewswire.com
Pelthos Therapeutics Q2 Earnings Call Highlights
Aug 14, 2026 · marketbeat.com
Data last updated: Nov 9, 2026, 04:30 AM